(R)-Lansoprazole Dexlansoprazole CAS 138530-94-6 Assay 98.0~102.0% (HPLC) Hale Hana

(R)-Lansoprazole (CAS: 138530-94-6) ʻo ia ka R enantiomer o Lansoprazole, Lansoprazole (AG 1749) he mea hoʻoheheʻe pāpaʻi proton e pale ana i ka ʻōpū mai ka hana ʻana i ka waikawa.ʻO Dexlansoprazole no Lansoprazole dextroisomer, he ʻano lāʻau lapaʻau anti-peptic ulcer no ka hoʻololi ʻana i nā derivatives benzimidazole, i loko o ka molecular structure i loko o ka element fluorine, ʻelua proton pump inhibitors omeprazole ma hope.Loaʻa i ka Dexlansoprazole ka hopena o ka pale ʻana i ka huna ʻana o ka waikawa gastric, ʻoi aku ka maikaʻi o ka hopena ma mua o nā lāʻau ʻē aʻe (Omeprazole, Pantoprazole, Rebela, Tetrazolium) hiki ke pale nui i ka hiki ʻana o ka maʻi maʻi.ʻOi aku ka maikaʻi ma mua o ka famotidine a i ʻole Omeprazole no ka hōʻino ʻana i ka mucosa gastric i hoʻoiho ʻia i ka waiʻona a me ka ʻeha duodenal i kumu nui ʻia e ka hypersecretion waikawa.Eia kekahi, ua like ka hopena anti Helicobacter pylori i ka huahana e like me ka hoʻomākaukau ʻana i ka bismuth, a hoʻohana ʻia no ka reflux esophagitis a me ka maʻi Zhuo AI.Ua loaʻa i ka Takeda Pharmaceuticals ka ʻae ʻia o dexlansoprazole, he ʻano hoʻokuʻu ʻelua o ka (R) -isomer o ka lansoprazole proton pump inhibitor (PPI) i mua i ka mākeke, mai ka FDA i Ianuali 2009. ʻO Dexlansoprazole kahi capsule hoʻokuʻu lohi no ka lāʻau lapaʻau waha. ʻO ka puʻuwai e pili ana me ka maʻi hōʻailona non-erosive gastroesophageal reflux (GERD), ka ho'ōla ʻana o ka esophagitis erosive (EE) a me ka mālama ʻana i ka EE i hoʻōla ʻia.